Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
Read Also
- 12-year-old shoots, kills black bear attacking his dad in Wisconsin
- Vladimir Kara-Murza: How I survived 11 months of torture in Putin’s gulag
- Hundreds defrauded in door-to-door Ontario scam, Canada-wide warrants issued
- Israeli front-controlled manufacturing process likeliest explanation for attacks on Hezbollah
- Attorney for notorious mobster Whitey Bulger to lead new prosecution of Karen Read
- Edmundo González, Venezuela’s Opposition Leader, Says He Was Forced to Sign Letter Recognizing Maduro
- ‘Throw them in the river’: Fort Saskatchewan mayor apologizes for feral cat remarks
- ‘Appalling’ rows over Sue Gray must stop, senior ministers say
- ‘I couldn’t stop crying’: Memorial grows for 5-year-old boy killed in home
- Former Coronation Street actor Geoff Hinsliff dies at 87
Latest CNBC
- The Fed has set out on a 'recalibration' of policy. Here's what Powell's new buzzword means
- Elon Musk’s X and Starlink face nearly $1 million in daily fines for alleged ban evasion in Brazil
- 'Very serious escalation': Lebanese ministers warn of a dangerous next 48 hours after pager and device attacks
- European markets close higher after Bank of England holds rates, Fed cuts
- CNBC's Inside India newsletter: Will India's lofty manufacturing ambitions bear fruit?
- CNBC's Inside India newsletter: Will India's lofty manufacturing ambitions bear fruit?
- 'Very serious escalation': Lebanese ministers warn of a dangerous next 48 hours after pager and device attacks
- Tesla’s Chinese rival Nio cuts price for new Onvo-branded car
- Trump Media shares slide with DJT sale restrictions set to lift
- Biden’s student debt forgiveness plan to remain blocked, federal judge orders